Mirum Pharmaceuticals Inc
MIRM
Equity
ISIN null / Valor 48639108
NASDAQ (2026-02-27)
USD 92.29+0.11%
Mirum Pharmaceuticals Inc
UMushroom community rating:
About company
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare liver diseases.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
96.5%1Y
301%3Y
403%5Y
Performance
40.1%1Y
45.7%3Y
51.5%5Y
Volatility
4743 M
Market cap (USD)
1,019,131
Daily traded volume (Shares)
41.795 / 41.01
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
0.00
Innovation:
0.00
Society:
0.00
Nature:
0.00
EQUITIES OF THE SAME SECTOR
